Consainsights logo
Mail Us
Reports > Food And Beverages > Human Milk Oligosaccharides Market Report

Human Milk Oligosaccharides Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the Human Milk Oligosaccharides (HMO) market, detailing market trends, size, forecasts from 2023 to 2033, and key industry insights. It covers market segmentation, regional analysis, and insights into global market leaders.

Metric Value
Study Period 2023 - 2033
2023 Market Size $1.80 Billion
CAGR (2023-2033) 7.2%
2033 Market Size $3.68 Billion
Top Companies Basel, Switzerland - Nestlé S.A., Global - DuPont de Nemours, Inc., Germany - Glycom A/S, USA - Abbott Laboratories
Last Modified Date 15 Nov 2024

Human Milk Oligosaccharides Market Report (2023 - 2033)

Human Milk Oligosaccharides Market Overview

The Human Milk Oligosaccharides industry is evolving rapidly with increasing innovation and competition amongst manufacturers. A notable trend in the industry includes the shift towards synthetic production methods to meet the rising demand for HMOs in infant formula, with companies investing in advanced biotechnological processes for scalability. Furthermore, robust partnerships between ingredient suppliers and food manufacturers are becoming increasingly common, fostering the development of novel applications of HMOs in dietary supplements and functional foods. Regulatory bodies across the globe are also showing heightened interest in the safety and efficacy of HMO usage, ensuring strict compliance to facilitate market growth. Understanding these dynamics is critical for stakeholders aiming to capture market opportunities in this nascent yet rapidly maturing industry.

What is the Market Size & CAGR of Human Milk Oligosaccharides market in 2023?

In 2023, the Human Milk Oligosaccharides market is estimated to reach approximately 2.0 billion USD, growing at a compound annual growth rate (CAGR) of around 10% through 2033. The market is driven by rising consumer awareness of health benefits associated with HMOs, alongside increasing sales of infant formula products containing these beneficial oligosaccharides. With a steadily growing birth rate globally and a simultaneous rise in premium baby food products, projections indicate strong demand that is expected to continue, spurred by ongoing research into the benefits of HMOs.

Human Milk Oligosaccharides Industry Analysis

The Human Milk Oligosaccharides industry is evolving rapidly with increasing innovation and competition amongst manufacturers. A notable trend in the industry includes the shift towards synthetic production methods to meet the rising demand for HMOs in infant formula, with companies investing in advanced biotechnological processes for scalability. Furthermore, robust partnerships between ingredient suppliers and food manufacturers are becoming increasingly common, fostering the development of novel applications of HMOs in dietary supplements and functional foods. Regulatory bodies across the globe are also showing heightened interest in the safety and efficacy of HMO usage, ensuring strict compliance to facilitate market growth. Understanding these dynamics is critical for stakeholders aiming to capture market opportunities in this nascent yet rapidly maturing industry.

Human Milk Oligosaccharides Market Segmentation and Scope

The Human Milk Oligosaccharides market can be segmented on the basis of source, application, and component. Key segments include: 1. By Source: Natural (breast milk) vs. Synthetic (produced through fermentation processes). 2. By Application: Infant formula, dietary supplements, functional foods, and pharmaceuticals. 3. By Component: Fucosyllactose, Lacto-N-neotetraose, and other oligosaccharides. Each of these segments holds significant market share, with infant formula being the largest contributor, indicating a growing consumer preference for enhanced nutritional profiles in infant feeding.

Request a custom research report for industry.

Human Milk Oligosaccharides Market Analysis Report by Region

Europe Human Milk Oligosaccharides Market Report:

The European market for HMOs is projected to expand from approximately 0.59 billion USD in 2023 to 1.21 billion USD by 2033. This growth is driven by strong regulations surrounding infant nutrition markets and increased R&D investments by key industry players focused on product innovation.

Asia Pacific Human Milk Oligosaccharides Market Report:

The Asia Pacific region represented a market size of approximately 0.32 billion USD in 2023 and is anticipated to grow to 0.66 billion USD by 2033. This growth is driven by increasing birth rates, rising disposable incomes, and expanding urbanization, which are leading to higher consumption of infant formula products enriched with HMOs.

North America Human Milk Oligosaccharides Market Report:

In North America, the market is estimated to be valued at 0.64 billion USD in 2023, expected to rise to 1.31 billion USD by 2033. Factors fueling this growth include high consumer awareness of pediatric health and rising demand for premium infant formula products fortified with human milk oligosaccharides.

South America Human Milk Oligosaccharides Market Report:

The South American market is currently valued at 0.17 billion USD in 2023, projected to reach 0.34 billion USD by 2033. Growth in this region is attributed to changing dietary habits and improved healthcare practices. Increasing awareness about the health benefits of HMOs is also influencing consumer choices in infant nutrition.

Middle East & Africa Human Milk Oligosaccharides Market Report:

The Middle East and Africa market is expected to see gradual growth, moving from 0.08 billion USD in 2023 to about 0.16 billion USD by 2033. Increasing awareness of nutritional science and a growing emphasis on infant health could serve as catalysts for this growth across the region.

Request a custom research report for industry.

Human Milk Oligosaccharides Market Analysis By Source

Global Human Milk Oligosaccharides Market, By Source Market Analysis (2023 - 2033)

The Human Milk Oligosaccharides market based on source is distinctive, encompassing breast milk and synthetic production. In 2023, breast milk-derived HMOs dominate the market with a size of 1.56 billion USD, projected to increase to 3.19 billion USD by 2033, indicating a strong consumer preference for natural products. Synthetic HMOs are also gaining traction, especially in formulated products, showing growth from 0.24 billion USD in 2023 to 0.49 billion USD by 2033, as manufacturers seek to innovate and reduce costs.

Human Milk Oligosaccharides Market Analysis By Application

Global Human Milk Oligosaccharides Market, By Application Market Analysis (2023 - 2033)

The application of Human Milk Oligosaccharides spans across infant formula, healthcare products, and dietary supplements among others. In 2023, the market was valued at 1.14 billion USD for infant formula, anticipated to double by 2033. This segment holds a substantial market share of around 63.18%. Healthcare applications also show promise, especially as awareness of gut health increases, with projected growth from 0.38 billion USD to 0.77 billion USD by 2033.

Human Milk Oligosaccharides Market Analysis By Component

Global Human Milk Oligosaccharides Market, By Component Market Analysis (2023 - 2033)

The components of the Human Milk Oligosaccharides market include fucosyllactose, Lacto-N-neotetraose, and other oligosaccharides. Fucosyllactose is the market leader, with a size of 1.14 billion USD in 2023, maintaining a share of 63.18%. Other components are also expected to grow, with lacto-N-neotetraose projected to increase from 0.38 billion USD to 0.77 billion USD by 2033.

Human Milk Oligosaccharides Market Analysis By End User

Global Human Milk Oligosaccharides Market, By End-User Market Analysis (2023 - 2033)

End-users of Human Milk Oligosaccharides primarily include food and beverage manufacturers, healthcare providers, and pharmaceutical companies. The food and beverage sector holds a significant market share of 63.18% with projected growth reflecting the increasing adoption of nutritionally dense foods targeting infants and children, while the pharmaceutical sector is expected to see gradual growth as more products emerge focusing on dietary supplements for health enhancement.

Human Milk Oligosaccharides Market Trends and Future Forecast

The Human Milk Oligosaccharides market is expected to witness transformative growth through 2033. Key trends include increasing investments in biotechnology for synthetic HMO production and heightened consumer awareness centered around gut health and immunity in infants. The forecast reveals an anticipated market value exceeding 4.0 billion USD by 2033, fueled by continuing innovations in product formulations and the wider application scope of HMOs across health and nutrition sectors. However, challenges such as regulatory hurdles and the need for scientific validation of health claims present potential barriers to market entry and expansion.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Human Milk Oligosaccharides Industry

Basel, Switzerland - Nestlé S.A.:

A global leader in nutrition, Nestlé manufactures a wide range of infant formulas enriched with HMOs designed to improve digestive health and immunity.

Global - DuPont de Nemours, Inc.:

DuPont has invested heavily in R&D for synthetic HMO production and engages in partnerships with infant formula brands worldwide.

Germany - Glycom A/S:

Glycom specializes in the research and development of HMOs and has established a strong foothold in the infant nutrition segment with innovative HMO products.

USA - Abbott Laboratories:

Abbott is a major player in the infant formula market, integrating HMOs into its products to meet consumer demands for nutritional advancement.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs